PDGFRL Antibody (1008804) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1723M
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 1008804
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human embryonic kidney cell, HEK293-derived human PDGFRL
Gln22-Ser375
Accession # Q15198
Gln22-Ser375
Accession # Q15198
Specificity
Detects human PDGFRL in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for PDGFRL Antibody (1008804) [DyLight 594]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PDGFRL
Long Name
Platelet-derived Growth Factor Receptor-like
Alternate Names
PDGFR-Like Protein, PDGRL, PRLTS
Additional PDGFRL Products
Product Documents for PDGFRL Antibody (1008804) [DyLight 594]
Product Specific Notices for PDGFRL Antibody (1008804) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...